Winter 2022 (Volume 32, Number 4)
Pediatrics Committee News
By Roberta Berard, MD, MSc, FRCPC
The CRA Pediatrics Committee is a diverse and active
group of 95 (and growing) pediatric rheumatologists,
trainees and researchers. Heading this
committee is the Pediatrics Executive Committee, which
oversees the work of several subcommittees including
Human Resources, Education, and a number of working
groups. Dr. Bobbi Berard became Chair of the Pediatrics
Executive Committee in February 2022, with
Luca stepping into the role of Vice-Chair, and Dr. Julie
Barsalou as Secretary. We would like to thank Dr. Ron
Laxer for his dedication to our committee and to the
CRA community, having served two terms as Chair, and
Dr. Deb Levy, who has completed her term as Past-Chair.
Our newest Executive members include Dr. Lily Lim
(member-at-large) and Dr. Lillian Lim (CRA board liaison).
The Pediatrics subcommittees have been very busy
over the last twelve months, offering a variety of educational
opportunities in addition to producing manuscripts
and guidance materials.
Here is a summary of some of the important work they
have done over the past year:
The Canadian Autoinflammatory Case Rounds
(CANaC) Steering Committee offered three
presentations for pediatric members and invited
guests on Cryopyrin Associated Periodic Syndrome
(CAPS), presented by Susa Benseler in March, on
interferonopathies, presented by Yanick Crow in June,
and on Tumor Necrosis Factor Receptor Associated
Periodic Syndrome (TRAPS), presented by Lori
Tucker in September.
- The Education Subcommittee offered two accredited
National Grand Rounds webinars: Lupus Nephritis,
hosted by Deb Levy and Sean Jackson in May, and
Temporomandibular Joint (TMJ) disease in juvenile
idiopathic arthritis (JIA), hosted by Marinka Twilt in
- The HR subcommittee surveyed division heads
at academic centres to determine potential job
opportunities in the next year and the next
and results will be forthcoming. Members of the
subcommittee are also spearheading a qualitative
study evaluating clinical care resources, structures
and processes that are in place within Canadian
pediatric rheumatology clinics and institutions.
- Pediatric members of the CRA Transition Working
Group contributed to the position paper which
was published on the CRA website in August, titled
"Bridging the Gaps: Optimizing the Transition from
Pediatric to Adult Rheumatology Care."
- In collaboration with the Guidelines Committee
and the Cochrane Musculoskeletal Group, the CRA’s
Recommendations for the Screening, Monitoring and
Treatment of Juvenile Idiopathic Arthritis–Associated
Uveitis were recently published in the Journal of
Rheumatology and on MAGICapp, led by Bobbi Berard
and Deb Levy.
- The Choosing Wisely recommendations for pediatric
rheumatology and pediatric sport and exercise
medicine are now available on the Choosing Wisely
Canada website. A draft manuscript will be submitted
shortly for publication.
- The Pediatrics Committee was pleased to collaborate
with the Therapeutics and Stakeholder Engagement
Committees to advocate for an extension of the
Trispan™ expiry date from August 2022 to August
2023. We will continue to be active until a more
permanent solution is found.
- The Pediatrics Committee and the Therapeutics
Committee also collaborated to update the
Biosimilars position statement and the Citrate-Free
Adalimumab position statement, both of which were
published last fall.
Finally, we would like to celebrate our extraordinary
colleagues, mentors, and friends who have retired this
year, Drs. Ciaran Duffy, Karen Duffy, and Rayfel Schneider.
We wish them the very best in their well-deserved
Roberta Berard, MD, MSc, FRCPC
Chair, CRA Pediatrics Committee
Associate Professor of Pediatrics, Western University
Division Director, Pediatric Rheumatology,
London Health Sciences Centre